Axa S.A. Icon PLC Transaction History

Axa S.A.

$29.5 Billion
Q1 2025

A detailed history of Axa S.A. transactions in Icon PLC stock. As of the latest transaction made, Axa S.A. holds 76,870 shares of ICLR stock, worth $10.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

76,870

Previous 95,870 19.82%

Holding current value

$10.4 Million

Previous $20.1 Million 33.09%

% of portfolio

0.05%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$174.99 - $222.58 $3.32 Million - $4.23 Million	-19,000 Reduced 19.82%	76,870 $13.5 Million
Q4 2024 Feb 14, 2025	BUY	$187.22 - $297.57 $5.89 Million - $9.36 Million	31,465 Added 48.85%	95,870 $20.1 Million
Q3 2024 Nov 14, 2024	BUY	$280.48 - $346.2 $2.43 Million - $2.99 Million	8,647 Added 15.51%	64,405 $18.5 Million
Q2 2024 Feb 25, 2025	SELL	$288.23 - $331.73 $11.6 Million - $13.3 Million	-40,112 Reduced 41.84%	55,758 $17.5 Million
Q2 2024 Aug 14, 2024	SELL	$288.23 - $331.73 $211,849 - $243,821	-735 Reduced 1.3%	55,758 $17.5 Million
Q1 2024 May 15, 2024	BUY	$247.84 - $340.0 $570,032 - $782,000	2,300 Added 4.24%	56,493 $19 Million
Q4 2023 Jul 16, 2024	SELL	$222.83 - $285.76 $512,509 - $657,248	-2,300 Reduced 4.07%	54,193 $15.3 Million
Q4 2023 Feb 14, 2024	SELL	$222.83 - $285.76 $1.45 Million - $1.86 Million	-6,513 Reduced 10.73%	54,193 $15.3 Million
Q3 2023 Nov 14, 2023	SELL	$236.44 - $265.62 $565,800 - $635,628	-2,393 Reduced 3.79%	60,706 $14.9 Million
Q3 2022 Feb 14, 2023	BUY	$183.25 - $247.5 $12,277 - $16,582	67 Added 0.11%	63,099 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$183.25 - $247.5 $12,277 - $16,582	67 Added 0.11%	63,099 $11.6 Million
Q2 2022 Feb 14, 2023	SELL	$197.3 - $261.32 $590,124 - $781,608	-2,991 Reduced 4.53%	63,032 $13.7 Million
Q2 2022 Aug 15, 2022	SELL	$197.3 - $261.32 $590,124 - $781,608	-2,991 Reduced 4.53%	63,032 $13.7 Million
Q1 2022 Feb 14, 2023	BUY	$216.09 - $296.03 $631,847 - $865,591	2,924 Added 4.63%	66,023 $16.1 Million
Q1 2022 May 13, 2022	SELL	$216.09 - $296.03 $91,838 - $125,812	-425 Reduced 0.64%	66,023 $16.1 Million
Q4 2021 Feb 14, 2022	SELL	$258.11 - $309.7 $1.55 Million - $1.86 Million	-6,018 Reduced 8.3%	66,448 $20.6 Million
Q3 2021 Nov 15, 2021	BUY	$208.53 - $283.04 $4.73 Million - $6.42 Million	22,685 Added 45.57%	72,466 $19 Million
Q1 2021 May 14, 2021	SELL	$171.87 - $220.96 $798,336 - $1.03 Million	-4,645 Reduced 8.53%	49,781 $9.78 Million
Q3 2020 Nov 13, 2020	BUY	$166.91 - $196.1 $571,833 - $671,838	3,426 Added 6.72%	54,426 $10.4 Million
Q2 2020 Aug 14, 2020	SELL	$129.79 - $170.94 $386,125 - $508,546	-2,975 Reduced 5.51%	51,000 $8.59 Million
Q1 2020 May 15, 2020	SELL	$115.95 - $177.22 $438,059 - $669,537	-3,778 Reduced 6.54%	53,975 $7.34 Million
Q3 2019 Nov 14, 2019	BUY	$146.89 - $161.41 $131,613 - $144,623	896 Added 1.58%	57,753 $8.51 Million
Q2 2019 Aug 13, 2019	BUY	$129.99 - $153.97 $822,966 - $974,784	6,331 Added 12.53%	56,857 $8.75 Million
Q1 2019 May 14, 2019	BUY	$121.3 - $146.95 $984,592 - $1.19 Million	8,117 Added 19.14%	50,526 $6.9 Million
Q4 2018 Feb 13, 2019	SELL	$119.37 - $153.29 $667,397 - $857,044	-5,591 Reduced 11.65%	42,409 $5.48 Million
Q3 2018 Nov 08, 2018	BUY	$131.3 - $153.75 $893,890 - $1.05 Million	6,808 Added 16.53%	48,000 $7.38 Million
Q2 2018 Aug 13, 2018	BUY	$111.38 - $137.03 $891,151 - $1.1 Million	8,001 Added 24.11%	41,192 $5.46 Million
Q1 2018 May 14, 2018	BUY	$103.82 - $123.9 $1.16 Million - $1.39 Million	11,180 Added 50.79%	33,191 $3.92 Million
Q4 2017 Feb 13, 2018	BUY	$111.14 - $123.05 $259,956 - $287,813	2,339 Added 11.89%	22,011 $2.47 Million
Q3 2017 Nov 13, 2017	BUY	$101.4 - $116.62 $1.99 Million - $2.29 Million	19,672	19,672 $2.24 Million

Others Institutions Holding ICLR

# of Institutions

618

Shares Held

74.3M

Call Options Held

83.2K

Put Options Held

128K

View Full List

About ICON PLC

Ticker ICLR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 81,526,600
Market Cap $11B
Description
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...

More about ICLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account